2TZ.STU Tianjin Zhong Xin Pharmaceutical Group Corporation Limited

Healthcare Pharmaceuticals Stuttgart Exchange
8.93 EUR
Close of Nov 3, 2026
1.96 2.80
Market cap
EUR 1.79B
P/E
16.6x
P/B
2.22x
ROE
21.7%
Dividend yield
26.04%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 2TZ.STU undervalued?

Graham number
Price8.93
Graham value6.98
Premium27.9%

2TZ.STU trades 27.9% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Tianjin Zhong Xin Pharmaceutical Group Corporation Limited fundamental analysis

No fundamental analysis for Tianjin Zhong Xin Pharmaceutical Group Corporation Limited yet.

Tianjin Zhong Xin Pharmaceutical Group Corporation Limited stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Tianjin Zhong Xin Pharmaceutical Group Corporation Limited

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, together with its subsidiaries, produces and sells traditional Chinese medicine, western medicine, and other products primarily in the People's Republic of China. The company manufactures and sells of biochemical pharmaceutical products. It also engages in research and development of chinese patent medicines, chemical raw materials and preparations, and nutritional supplements. In addition, the company is involved…

Full company profile